- Home
- TNK vs VRDN Comparison
TNK vs VRDN Comparison
Compare TNK & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNK
- VRDN
- Stock Information
- Founded
- TNK 2007
- VRDN 2006
- Country
- TNK Bermuda
- VRDN United States
- Employees
- TNK N/A
- VRDN N/A
- Industry
- TNK Marine Transportation
- VRDN Medical Specialities
- Sector
- TNK Consumer Discretionary
- VRDN Health Care
- Exchange
- TNK Nasdaq
- VRDN Nasdaq
- Market Cap
- TNK 1.8B
- VRDN 1.5B
- IPO Year
- TNK 2007
- VRDN N/A
- Fundamental
- Price
- TNK $55.98
- VRDN $18.01
- Analyst Decision
- TNK Buy
- VRDN Strong Buy
- Analyst Count
- TNK 3
- VRDN 11
- Target Price
- TNK $50.67
- VRDN $38.80
- AVG Volume (30 Days)
- TNK 562.1K
- VRDN 875.0K
- Earning Date
- TNK 10-29-2025
- VRDN 11-11-2025
- Dividend Yield
- TNK 3.57%
- VRDN N/A
- EPS Growth
- TNK N/A
- VRDN N/A
- EPS
- TNK 8.13
- VRDN N/A
- Revenue
- TNK $997,294,000.00
- VRDN $305,000.00
- Revenue This Year
- TNK N/A
- VRDN N/A
- Revenue Next Year
- TNK $10.32
- VRDN $35,092.81
- P/E Ratio
- TNK $6.88
- VRDN N/A
- Revenue Growth
- TNK N/A
- VRDN 5.90
- 52 Week Low
- TNK $33.35
- VRDN $9.90
- 52 Week High
- TNK $62.45
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- TNK 77.57
- VRDN 45.76
- Support Level
- TNK $50.95
- VRDN $18.12
- Resistance Level
- TNK $53.89
- VRDN $20.51
- Average True Range (ATR)
- TNK 1.45
- VRDN 0.93
- MACD
- TNK 0.42
- VRDN -0.12
- Stochastic Oscillator
- TNK 95.09
- VRDN 3.85
About TNK Teekay Tankers Ltd.
Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).